{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:32:26Z","timestamp":1754152346726,"version":"3.41.2"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science Foundation of Zhejiang Province","award":["LTGY23H160032"],"award-info":[{"award-number":["LTGY23H160032"]}]},{"name":"Key Research and Development Select Projects of Zhejiang Provincial Department of Science and Technology","award":["2020C03008"],"award-info":[{"award-number":["2020C03008"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Lung cancer is one of the most prevalent malignancies worldwide, and the metastasis of nonsmall cell lung cancer often leads to rapid deterioration of patient conditions, with brain metastasis (BM) being the most detrimental. The mechanisms underlying lung cancer brain metastasis remain incompletely understood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>This study aimed to elucidate the molecular mechanisms of lung cancer brain metastasis and identify potential biomarkers and therapeutic targets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The high invasiveness of H1975-BM51 cells was verified using Western blotting, cell invasion assays, and the establishment of an nonsmall cell lung cancer brain metastasis mouse model. Transcriptome sequencing of H1975 and H1975-BM51 cells was conducted, followed by Least Absolute Shrinkage and Selection Operator regression and single-gene Gene Set Enrichment Analysis to screen key genes. Quantitative real-time PCR and Western blotting were employed to detect the expression levels of the AGO3 gene in H1975-BM51 cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Transcriptomic analysis revealed that the AGO3 gene contributes to lung cancer brain metastasis by negatively regulating hormone metabolic processes. Compared with parental H1975 cells, both mRNA and protein expression levels of AGO3 were significantly upregulated in highly invasive H1975-BM51 cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study identifies AGO3 as a potential biomarker and therapeutic target for lung cancer brain metastasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043483","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:00:42Z","timestamp":1753156842000},"page":"e43483","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of biomarkers for brain metastasis in nonsmall cell lung cancer based on transcriptome sequencing"],"prefix":"10.1097","volume":"104","author":[{"given":"Liangting","family":"Tan","sequence":"first","affiliation":[{"name":"Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Jianghan University, School of Medicine, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyi","family":"Qian","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qikun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuran","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhong","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Jianghan University, School of Medicine, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-7455","authenticated-orcid":false,"given":"Xiaoliang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.7150\/jca.53613","article-title":"PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway.","volume":"12","author":"Xu","year":"2021","journal-title":"J Cancer"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China.","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.1016\/j.ctrv.2021.102291","article-title":"Brain metastases in patients with oncogenic-driven non-small cell lung cancer: pros and cons for early radiotherapy.","volume":"100","author":"Lee","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/neuonc\/noaa028","article-title":"ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium.","volume":"22","author":"M\u00fcnsterberg","year":"2020","journal-title":"Neuro Oncol"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mri.2020.03.002","article-title":"Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.","volume":"69","author":"Chen","year":"2020","journal-title":"Magn Reson Imaging"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2017.00230","article-title":"Genetic characterization of brain metastases in the era of targeted therapy.","volume":"7","author":"Han","year":"2017","journal-title":"Front Oncol"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jtho.2016.06.002","article-title":"Brain Metastases from NSCLC: radiation therapy in the era of targeted therapies.","volume":"11","author":"Khalifa","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2407-9-119","article-title":"Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis.","volume":"9","author":"Arrieta","year":"2009","journal-title":"BMC Cancer"},{"key":"R9-20250722","first-page":"71","article-title":"ALESIA 5-Year update: alectinib at 600\u2009mg twice daily gives lorlatinib a run for its money in Asia.","volume":"14","author":"Lee","year":"2023","journal-title":"Lung Cancer (Auckl)"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.7150\/jca.101330","article-title":"Immunofluorescence-verified sphingolipid signatures indicate improved prognosis in liver cancer patients.","volume":"15","author":"Pan","year":"2024","journal-title":"J Cancer"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7150\/jca.89338","article-title":"Interplay of sphingolipid metabolism in predicting prognosis of GBM patients: towards precision immunotherapy.","volume":"15","author":"Wang","year":"2024","journal-title":"J Cancer"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"e3580","DOI":"10.1002\/jgm.3580","article-title":"Multi-omics analysis reveals that ferroptosis-related gene CISD2 is a prognostic biomarker of head and neck squamous cell carcinoma.","volume":"26","author":"Li","year":"2024","journal-title":"J Gene Med"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12920-023-01688-4","article-title":"Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma.","volume":"16","author":"Zhao","year":"2023","journal-title":"BMC Med Genomics"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-019-1092-4","article-title":"LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K\/AKT\/MYC pathway.","volume":"38","author":"Wei","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1634\/theoncologist.12-7-884","article-title":"Multidisciplinary management of brain metastases.","volume":"12","author":"Eichler","year":"2007","journal-title":"Oncologist"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","article-title":"Management of brain metastases.","volume":"249","author":"Soffietti","year":"2002","journal-title":"J Neurol"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/neuonc\/nou099","article-title":"Incidence of brain metastasis at initial presentation of lung cancer.","volume":"17","author":"Villano","year":"2015","journal-title":"Neuro Oncol"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21818","article-title":"Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.","volume":"106","author":"Hu","year":"2006","journal-title":"Cancer"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02782192","article-title":"Long-term survival with metastatic cancer to the brain.","volume":"17","author":"Hall","year":"2000","journal-title":"Med Oncol"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.3747\/co.20.1481","article-title":"Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.","volume":"20","author":"Ali","year":"2013","journal-title":"Curr Oncol"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/now197","article-title":"Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol"},{"issue":"Suppl 4","key":"R22-20250722","first-page":"S256","article-title":"Seed, soil, and beyond: The basic biology of brain metastasis.","volume":"4","author":"Ramakrishna","year":"2013","journal-title":"Surg Neurol Int"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13058-015-0665-1","article-title":"Breast cancer brain metastases: biology and new clinical perspectives.","volume":"18","author":"Witzel","year":"2016","journal-title":"Breast Cancer Res"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s12094-024-03697-w","article-title":"Tumor microenvironment as a complex milieu driving cancer progression: a mini review.","volume":"27","author":"Li","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.isci.2018.04.013","article-title":"Mitochondria-targeted honokiol confers a striking inhibitory effect on lung cancer via inhibiting complex I activity.","volume":"3","author":"Pan","year":"2018","journal-title":"iScience"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc3053","article-title":"Brain metastases as preventive and therapeutic targets.","volume":"11","author":"Steeg","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1517\/14656561003702412","article-title":"Systemic treatment in breast-cancer patients with brain metastasis.","volume":"11","author":"Arslan","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders.","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"R29-20250722","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease.","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann Neurol"},{"key":"R30-20250722","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-12-2851","article-title":"Molecular pathways: ROS1 fusion proteins in cancer.","volume":"19","author":"Davies","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41571-020-0408-9","article-title":"ROS1-dependent cancers - biology, diagnostics and therapeutics.","volume":"18","author":"Drilon","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R32-20250722","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer.","volume":"371","author":"Shaw","year":"2014","journal-title":"N Engl J Med"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdz131","article-title":"Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.","volume":"30","author":"Shaw","year":"2019","journal-title":"Ann Oncol"},{"key":"R34-20250722","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1470-2045(19)30690-4","article-title":"Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.","volume":"21","author":"Drilon","year":"2020","journal-title":"Lancet Oncol"},{"key":"R35-20250722","first-page":"100332","article-title":"Long-Term efficacy and safety of entrectinib in ROS1 Fusion-Positive NSCLC.","volume":"3","author":"Drilon","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"R36-20250722","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/ol.2025.14943","article-title":"Pan\u2011immune\u2011inflammatory values predict survival in patients after radical surgery for non\u2011metastatic colorectal cancer: a retrospective study.","volume":"29","author":"Li","year":"2025","journal-title":"Oncol Lett"},{"key":"R37-20250722","doi-asserted-by":"crossref","first-page":"11517","DOI":"10.1038\/s41598-025-96592-5","article-title":"Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage I-III colorectal cancer.","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:00:46Z","timestamp":1753156846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":37,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043483","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}